NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2025
Back to search
Official data from USPTO
CLINLIFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINLIFE
ST13
US500000079360372Class
35, 38, 41, 42, 44
Filing
79360372
Registration
7423869
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
11/16/2025
Trademark type
Word
Nice classes
35, 38, 41, 42, 44
Filing date
10/24/2022
Registration date
06/25/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
11/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
BLAKESLEE,RICHARD A
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Clariness GmbH
Representatives
Gabrielle A. Holley Holley & Menker, P.A.
Technical classification
Nice Classes
Class 35Class 38Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Recruitment and placement of participants in scientific and clinical studies with pharmaceutical preparations; presentation of goods and services for third partiesin particular on the internet for retail purposes; managed business servicesarranging contracts for services for third parties; advertising on the internet for third parties; all aforementioned servicesin particular in the medical and pharmaceutical field; wholesale and retail store services featuring medical and pharmaceutical goods and body and beauty care products; collection of data for business purposesin particular data on scientific or clinical studies and diseases; provision of business statistical information relating to medical matters
Class 38
Transmission of information by electronic communications networksforwarding of informationin particular on scientific or clinical studies and diseasesvia electronic communication mediain particular via Internet platformse-mail newsletters and mobile phone messages; provision of access to databases in the nature of interactive electronic platforms for communication and exchange of data and information of all kindsin particular via chat lineschat rooms and Internet forums; e-mail forwarding services; web messaging in the nature of forwarding of messages to Internet addresses; provision of user access to computer programmes in data networks
Class 41
Educational servicesproviding classesseminarsworkshops in the medicalpharmaceutical and clinical trial fields; training services in the medicalpharmaceutical and clinical trial fields; entertainment in the nature of providing ongoing online programs in the medicalpharmaceutical and clinical trial fields; organizing community sporting and cultural activitiesin particular in the field of health; publication of printed matter and electronic publications containing informationin particular on scientific and clinical studies with pharmaceutical preparations and diseases; distribution of radio and television programmes
Class 42
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of information and data relating to medical and veterinary research and development
Class 44
Providing information relating to medical services; providing medical information in the healthcare sector
Publications
History of USPTO decisions and trademark events.
29 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/28/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/09/2024
FIMP
FINAL DISPOSITION PROCESSED
12/09/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/25/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/25/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/10/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/15/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/27/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/23/2024
RFNT
REFUSAL PROCESSED BY IB
09/26/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/01/2023
RFRR
REFUSAL PROCESSED BY MPU
09/01/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/12/2023
CNRT
NON-FINAL ACTION WRITTEN
08/11/2023
DOCK
ASSIGNED TO EXAMINER
08/08/2023
MAFR
APPLICATION FILING RECEIPT MAILED
01/18/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/14/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/12/2023
Continuous trademark protection
Get notified about every new filing that threatens CLINLIFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.